Candidacy for sorafenib in HCC patients: is there a slippery slope beyond a SHARP edge?

Oncology (Williston Park, N.Y.)

Volumn 25, Issue 3, 2011, Pages

  Burak, Kelly W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; PYRIDINE DERIVATIVE; SORAFENIB;

CLINICAL TRIAL (TOPIC); HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; NOTE;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIALS AS TOPIC; HUMANS; LIVER NEOPLASMS; PYRIDINES;

EID: 79956308128     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)